⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EZRA News
Reliance Global Group, Inc. Common Stock
Form 8-K
sec.gov
EZRA
Reliance Global Group Announces Reverse Stock Split
globenewswire.com
EZRA
Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments
globenewswire.com
EZRA
Form 8-K
sec.gov
EZRA
Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call
globenewswire.com
EZRA
Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment
globenewswire.com
EZRA
Form 8-K
sec.gov
EZRA
Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division
globenewswire.com
EZRA
Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones
globenewswire.com
EZRA
Reliance Global Group to Participate in Centri Capital Conference at Nasdaq MarketSite in New York City on April 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
EZRA